Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 63

1.

Efficacy and safety of etanercept in enthesitis-related arthritis juvenile idiopathic arthritis: Results from a phase 3 randomized double-blind study.

Horneff G, Foeldvari I, Minden K, Trauzeddel R, Kümmerle-Deschner JB, Tenbrock K, Ganser G, Huppertz HI.

Arthritis Rheumatol. 2015 Apr 17. doi: 10.1002/art.39145. [Epub ahead of print]

PMID:
25891010
2.

Prevalence of overweight in children and adolescents with juvenile idiopathic arthritis.

Schenck S, Niewerth M, Sengler C, Trauzeddel R, Thon A, Minden K, Klotsche J.

Scand J Rheumatol. 2015 Mar 6:1-8. [Epub ahead of print]

PMID:
25742802
3.

Uveitis in juvenile idiopathic arthritis.

Heiligenhaus A, Minden K, Föll D, Pleyer U.

Dtsch Arztebl Int. 2015 Feb 6;112(6):92-100, i. doi: 10.3238/arztebl.2015.0092.

4.

Effect of methotrexate on the mandibular development of arthritic rabbits.

Präger TM, Meyer P, Rafayelyan S, Minden K, Jost-Brinkmann PG.

Eur J Orthod. 2014 Dec 17. pii: cju070. [Epub ahead of print]

PMID:
25518996
5.

[Immunization in children and adolescents with rheumatic and musculoskeletal diseases].

Minden K, Speth F, Huppertz HI, Borte M.

Z Rheumatol. 2014 Dec;73(10):878-89. doi: 10.1007/s00393-014-1396-x. German.

PMID:
25479932
6.

Skin manifestations associated with chronic recurrent multifocal osteomyelitis in a 9-year-old girl.

Bachmann F, Stieler K, Garcia Bartels N, Philipp S, Minden K, Blume-Peytavi U.

J Am Acad Dermatol. 2014 Nov;71(5):e218-9. doi: 10.1016/j.jaad.2014.07.022. Epub 2014 Oct 15. No abstract available.

7.

[Current news from the BIKER register].

Horneff G, Minden K, Foeldvari I, Onken N, Windschall D, Hospach A, Ganser G, Klotsche J, Becker I; BIKER-Register Studiengruppe.

Z Rheumatol. 2014 Dec;73(10):897-906. doi: 10.1007/s00393-014-1397-9. German.

PMID:
25269873
8.

Effect of methotrexate upon antigen-induced arthritis of the rabbit temporomandibular joint.

Rafayelyan S, Meyer P, Radlanski RJ, Minden K, Jost-Brinkmann PG, Präger TM.

J Oral Pathol Med. 2014 Sep 22. doi: 10.1111/jop.12265. [Epub ahead of print]

PMID:
25243828
9.

[Therapy of juvenile idiopathic arthritis in early adulthood with biologics: transition from pediatric to adult care].

Niewerth M, Minden K, Klotsche J, Horneff G.

Z Rheumatol. 2014 Aug;73(6):532-40. doi: 10.1007/s00393-014-1378-z. German.

PMID:
25096586
10.

[Berlin transition program: from adolescents to adults in rheumatology treatment].

Minden K, Niewerth M, Müther S.

Z Rheumatol. 2014 Aug;73(6):526-31. doi: 10.1007/s00393-014-1377-0. German.

PMID:
25037479
11.

Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry.

Schmeling H, Minden K, Foeldvari I, Ganser G, Hospach T, Horneff G.

Arthritis Rheumatol. 2014 Sep;66(9):2580-9. doi: 10.1002/art.38741.

PMID:
24942886
12.

Histomorphometry in antigen-induced arthritis of the rabbit temporomandibular joint.

Rafayelyan S, Radlanski RJ, Minden K, Pischon N, Jost-Brinkmann PG, Präger TM.

J Oral Pathol Med. 2015 Jan;44(1):67-74. doi: 10.1111/jop.12201. Epub 2014 Jun 16.

PMID:
24935724
13.

Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases.

Sengler C, Niewerth M, Kallinich T, Nimtz-Talaska A, Haller M, Huppertz HI, Minden K.

Clin Rheumatol. 2014 Jan;33(1):137-9. doi: 10.1007/s10067-013-2435-8. Epub 2013 Nov 28.

PMID:
24288046
14.

Improvement in health-related quality of life for children with juvenile idiopathic arthritis after start of treatment with etanercept.

Klotsche J, Minden K, Thon A, Ganser G, Urban A, Horneff G.

Arthritis Care Res (Hoboken). 2014 Feb;66(2):253-62. doi: 10.1002/acr.22112.

PMID:
23983081
15.

[Transition of care from the perspective of pediatric rheumatology].

Minden K, Niewerth M.

Z Rheumatol. 2013 Oct;72(8):750-5. doi: 10.1007/s00393-013-1226-6. German. No abstract available.

PMID:
23872703
16.

Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors.

Heiligenhaus A, Heinz C, Edelsten C, Kotaniemi K, Minden K.

Ocul Immunol Inflamm. 2013 Jun;21(3):180-91. doi: 10.3109/09273948.2013.791701. Review.

PMID:
23713827
17.

Comorbidity profiles among adult patients with juvenile idiopathic arthritis: results of a biologic register.

Raab A, Sengler C, Niewerth M, Klotsche J, Horneff G, Zink A, Girschick H, Weber K, Minden K.

Clin Exp Rheumatol. 2013 Sep-Oct;31(5):796-802. Epub 2013 Apr 2.

PMID:
23557722
18.

[Biologics register JuMBO. Long-term safety of biologic therapy of juvenile idiopathic arthritis].

Minden K, Klotsche J, Niewerth M, Horneff G, Zink A.

Z Rheumatol. 2013 May;72(4):339-46. doi: 10.1007/s00393-012-1063-z. German.

PMID:
23456365
19.

Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement.

Horneff G, Fitter S, Foeldvari I, Minden K, Kuemmerle-Deschner J, Tzaribacev N, Thon A, Borte M, Ganser G, Trauzeddel R, Huppertz HI.

Arthritis Res Ther. 2012 Oct 24;14(5):R230. doi: 10.1186/ar4072.

20.

Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study.

Gerss J, Roth J, Holzinger D, Ruperto N, Wittkowski H, Frosch M, Wulffraat N, Wedderburn L, Stanevicha V, Mihaylova D, Harjacek M, Len C, Toppino C, Masi M, Minden K, Saurenmann T, Uziel Y, Vesely R, Apaz MT, Kuester RM, Elorduy MJ, Burgos-Vargas R, Ioseliani M, Magni-Manzoni S, Unsal E, Anton J, Balogh Z, Hagelberg S, Mazur-Zielinska H, Tauber T, Martini A, Foell D; Paediatric Rheumatology International Trials Organization (PRINTO).

Ann Rheum Dis. 2012 Dec;71(12):1991-7. doi: 10.1136/annrheumdis-2012-201329. Epub 2012 Jun 11.

PMID:
22689317
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk